Cost-effectiveness of Polypills, Obesity and FH, Adverse Pregnancy Outcomes and Long-term HF Risk
Eagle's Eye View: Your Weekly CV Update From ACC.org
00:00
Exploring Cost-Effectiveness and Cardiovascular Risks in Vulnerable Populations
This chapter explores the cost-effectiveness of a cardiovascular polypill for vulnerable populations, highlighting its potential benefits. It also addresses obesity-related risks in patients with familial hyperlipidemia and connects adverse pregnancy outcomes to long-term cardiovascular health.
Transcript
Play full episode
